The State Street SPDR S&P Biotech ETF (Symbol: XBI) recorded an inflow of approximately $289.4 million, reflecting a 2.6% week-over-week increase in outstanding units from 68,425,000 to 70,175,000. This data was noted during the trading session on [insert date] at [insert location, if applicable].
XBI’s 52-week share price range highlights a low of $92.49 and a high of $169.89, with the last trade recorded at $163.28. The ETF’s significant inflow suggests increased investor demand, which may influence its underlying components, including Twist Bioscience Corp (Symbol: TWST), Apogee Therapeutics Inc (Symbol: APGE), and Kymera Therapeutics Inc (Symbol: KYMR).
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
